Halozyme Therapeutics, Inc. (HALO) quarterly cash flow statement — complete operating, investing & financing history
Halozyme Therapeutics, Inc. (HALO) cash flow statement — 25-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | 240.89M | 180.08M | 219.03M | 178.6M | 99.71M | 154.22M | 178.47M | 115.38M | 55.79M | 129.43M | 102.35M | 132.41M | 66.84M | 86.96M | 82.45M | 69.64M | 40.23M | 47.8M | 82.52M | 121.74M |
| Operating CF Margin % | 50.08% | 47.8% | 48.48% | 50.41% | 30.61% | 58.23% | 59.89% | 39.77% | 24.12% | 66.07% | 44.49% | 61.29% | 30.24% | 53.63% | 45.43% | 33.32% | 26.4% | 40.76% | 80.9% | 105.1% |
| Operating CF Growth % | 141.59% | 16.77% | 22.73% | 54.8% | 78.71% | 19.16% | 74.36% | -12.87% | -16.53% | 48.83% | 24.14% | 90.15% | 66.17% | 81.94% | -0.08% | -42.8% | 9.04% | -18.01% | 62.05% | 1900.97% |
| Net Income | 229.91M | 150.05M | -141.59M | 175.22M | 165.16M | 118.09M | 137.01M | 137.01M | 93.25M | 76.82M | 85.39M | 81.84M | 74.75M | 39.62M | 57.7M | 61.63M | 22.68M | 60.11M | 66.77M | 216.59M |
| Depreciation & Amortization | 33.97M | 33.73M | 26.68M | 22.28M | 22.35M | 20.45M | 22.26M | 20.36M | 22.17M | 22.04M | 22.52M | 22.4M | 22.45M | 22.29M | 8.95M | 33.13M | 13.66M | 1.75M | 1.74M | 1.72M |
| Stock-Based Compensation | 17.7M | 16.64M | 16.57M | 12.16M | 12.16M | 10.67M | 11.46M | 12.58M | 9.47M | 9.87M | 9.66M | 9.37M | 9.62M | 7.97M | 7.22M | 6.8M | 5.63M | 4.74M | 5.13M | 5.4M |
| Deferred Taxes | 907K | 3.43M | -16.77M | 0 | 0 | -2.86M | 0 | 292K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -67.79M | 2.43M | 343.57M | 20.05M | -37.64M | 390K | 32.55M | -926K | 14.48M | 17.82M | 1.4M | -5.23M | 31.39M | -20.73M | 13.99M | 22.56M | 23.19M | 6.86M | -9.42M | -145.11M |
| Working Capital Changes | 26.2M | -26.2M | -9.43M | -51.12M | -62.33M | 7.47M | -24.82M | -53.94M | -83.57M | 2.87M | -16.62M | 24.04M | -71.36M | 37.82M | -5.41M | -54.48M | -24.94M | -25.66M | 18.3M | 43.14M |
| Change in Receivables | 2.16M | -19.55M | -90.48M | -29.7M | -11.72M | 3.83M | -22.71M | -71.22M | -18.62M | 38.31M | -16.89M | 28.85M | -51.5M | 36.19M | -7.75M | -43.93M | -9.46M | -22.79M | 21.12M | 41.1M |
| Change in Inventory | 18.33M | 27.38M | 18.78M | -1.1M | -14.54M | -586K | -7.73M | 1.98M | -21.4M | -40.23M | 1.47M | 3.63M | -24.74M | -7.25M | -2.94M | -5.51M | -15.32M | 6.3M | 2.22M | 2.73M |
| Change in Payables | -47.83M | 0 | 0 | 0 | 0 | 0 | 0 | -21.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -62.66M | -2.88M | -741.79M | 201.61M | 84.79M | -90.42M | 29.48M | -167.48M | -42.04M | -82.68M | -8.29M | -83.45M | 54.99M | -60.16M | -1.75M | -1.01M | -434.95M | -49.3M | -299.47M | -16.95M |
| Capital Expenditures | -4.17M | -3.74M | -1.43M | -3.03M | -1.56M | -950K | -3.05M | -1.52M | -2.58M | -3.54M | -2.6M | -2.94M | 1.62M | -11.38M | -2.34M | -1.01M | -968K | -490K | -158K | -496K |
| CapEx % of Revenue | 0.87% | 0.99% | 0.32% | 0.86% | 0.48% | 0.36% | 1.02% | 0.52% | 1.12% | 1.81% | 1.13% | 1.36% | 0.73% | 7.02% | 1.29% | 0.48% | 0.64% | 0.42% | 0.15% | 0.43% |
| Acquisitions | -710K | 710K | -1.01B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -999.12M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 710K | 0 | 0 | 204.64M | 86.35M | 0 | 32.53M | 0 | -39.46M | -79.14M | -5.7M | -80.51M | 53.37M | -48.78M | 598K | 0 | 565.14M | -48.81M | -299.31M | -16.46M |
| Cash from Financing | -326.25M | -1.61M | 239.51M | -22.4M | -298.97M | -3.32M | -246.41M | 18.56M | 9.48M | -489K | -249.92M | 4.1M | 2.45M | -164.61M | 6.33M | -12.4M | 367.82M | 624K | -156.01M | -60.07M |
| Debt Issued (Net) | 0 | 0 | 235.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.48M | 0 | 702M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -1.61M | 4.15M | -38.88M | -300.17M | -3.32M | -250M | 18.56M | 8.99M | -489K | -252.3M | 0 | 1.05M | -151.13M | -1K | -200M | 0 | 0 | -160.32M | -64.72M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -332.73M | 0 | 0 | -38.88M | -300.17M | 0 | -250M | 0 | 0 | -489K | -252.3M | 0 | 1.05M | -151.13M | -1K | -200M | 0 | 0 | -160.32M | -64.72M |
| Other Financing | -326.25M | 0 | 0 | 16.48M | 1.2M | 0 | 3.58M | 0 | 489K | 0 | 2.38M | 4.1M | 1.4M | 0 | 6.33M | -514.4M | 367.82M | 624K | 4.31M | 4.65M |
| Net Change in Cash | -148.02M | 175.93M | -285.85M | 357.8M | -114.47M | 60.48M | -38.47M | -33.55M | 23.24M | 46.26M | -155.86M | 53.06M | 124.28M | -137.81M | 87.04M | 56.23M | -26.9M | -884K | -372.96M | 44.72M |
| Free Cash Flow | 236.72M | 176.34M | 217.6M | 175.57M | 98.15M | 153.27M | 175.41M | 113.86M | 53.21M | 125.88M | 99.76M | 129.47M | 68.47M | 75.59M | 80.11M | 68.63M | 39.26M | 47.31M | 82.36M | 121.24M |
| FCF Margin % | 49.21% | 46.81% | 48.17% | 49.56% | 30.13% | 57.87% | 58.86% | 39.25% | 23% | 64.27% | 43.37% | 59.93% | 30.97% | 46.62% | 44.14% | 32.84% | 25.77% | 40.34% | 80.74% | 104.67% |
| FCF Growth % | 141.18% | 15.05% | 24.05% | 54.2% | 84.45% | 21.76% | 75.84% | -12.06% | -22.28% | 66.54% | 24.53% | 88.65% | 74.4% | 59.78% | -2.73% | -43.4% | 7.98% | -18.47% | 67.32% | 1952.18% |
| FCF per Share | 1.95 | 1.44 | 1.85 | 1.44 | 0.79 | 1.21 | 1.36 | 0.87 | 0.41 | 0.98 | 0.76 | 0.97 | 0.51 | 0.55 | 0.58 | 0.49 | 0.28 | 0.33 | 0.57 | 0.83 |
| FCF Conversion (FCF/Net Income) | 1.05x | 1.20x | -1.55x | 1.02x | 0.60x | 1.31x | 1.30x | 0.84x | 0.60x | 1.68x | 1.20x | 1.62x | 0.89x | 2.20x | 1.43x | 1.13x | 1.77x | 0.80x | 1.24x | 0.56x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 10.56M | 0 | 0 | 0 | 11.41M | 0 | 0 | 0 | 6.11M | 0 | 0 | 0 | 3.3M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |